Stefani Spranger Explores the Absence of T Cells in Melanoma Subtypes
Stefani Spranger, PhD, postdoctoral fellow at the University of Chicago, discusses recent findings about why a certain subgroup of patients with melanoma do not have T cells within their tumor microenvironment.
Stefani Spranger, PhD, postdoctoral fellow at the University of Chicago, discusses recent findings about why a subgroup of patients with melanoma do not have T cells within their tumor microenvironment.
At the 2016 Society for Melanoma Research (SMR) Congress, Spranger discussed her findings that upregulation of the WNT/beta-catenin pathway within the tumor cell mediates the exclusion of T cells from the microenvironment. This is because a subtype of dendritic cells (CD141-positive) must be present to recruit T cells back into the tumor.
